Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Semaglutide is a GLP-1 receptor agonist
Metabolic Pharmaceuticals Phase IIb obesity program completed but did not advance to registration
For comprehensive storage recommendations across all forms, see our peptide shelf life guide
Types of Reclassification (Switching) The legal status of a medicine is changed when there is growing confidence in the medicines action and safety profile
[1] Other rare side effects noted (mostly in older literature or high-dose use) include: polycythemia vera and peripheral vascular thrombosis in patients receiving repeated injections (though these associations are not well understood, they were listed in prior product literature as possible adverse events)
US$ 26.77
US$ 29.52
US$ 27.42
US$ 24.17
